These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12641657)

  • 1. Expression of transforming growth factor-beta isoforms and their receptors in lepromatous and tuberculoid leprosy.
    Kiszewski CA; Becerril E; Baquera J; Aguilar LD; Hernández-Pando R
    Scand J Immunol; 2003 Mar; 57(3):279-85. PubMed ID: 12641657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.
    Goulart IM; Figueiredo F; Coimbra T; Foss NT
    Am J Pathol; 1996 Mar; 148(3):911-7. PubMed ID: 8774145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in TGF-β secreting CD4⁺CD25⁺ FOXP3⁺ T regulatory cells in anergic lepromatous leprosy patients.
    Saini C; Ramesh V; Nath I
    PLoS Negl Trop Dis; 2014; 8(1):e2639. PubMed ID: 24454972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclooxygenase type 2 in lepromatous and tuberculoid leprosy lesions.
    Kiszewski AE; Becerril E; Baquera J; Ruiz-Maldonado R; Hernández Pando R
    Br J Dermatol; 2003 Apr; 148(4):795-8. PubMed ID: 12752141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
    De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ expression of M2 macrophage subpopulation in leprosy skin lesions.
    de Sousa JR; de Sousa RP; Aarão TL; Dias LB; Carneiro FR; Fuzii HT; Quaresma JA
    Acta Trop; 2016 May; 157():108-14. PubMed ID: 26827741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
    Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL
    J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles in paraffin-embedded biopsy samples of lepromatous leprosy patients: semi-quantitative measure of cytokine mRNA using RT-PCR.
    Shabaana AK; Venkatasubramani R; Narayan NS; Hoessli DC; Dharmalingam K
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):204-14. PubMed ID: 11875764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodular leprosy of childhood and tuberculoid leprosy: a comparative, morphologic, immunopathologic and quantitative study of skin tissue reaction.
    Fakhouri R; Sotto MN; Manini MI; Margarido LC
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):218-26. PubMed ID: 14608817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th9 cytokines response and its possible implications in the immunopathogenesis of leprosy.
    de Sousa JR; Pagliari C; de Almeida DSM; Barros LFL; Carneiro FRO; Dias LB; de Souza Aarão TL; Quaresma JAS
    J Clin Pathol; 2017 Jun; 70(6):521-527. PubMed ID: 27927694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and skin lesion cytokine profile in Brazilian patients with borderline tuberculoid and borderline lepromatous leprosy.
    Venturini J; Soares CT; Belone Ade F; Barreto JA; Ura S; Lauris JR; Vilani-Moreno FR
    Lepr Rev; 2011 Mar; 82(1):25-35. PubMed ID: 21644469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor β and apoptosis in leprosy skin lesions: possible relationship with the control of the tissue immune response in the Mycobacterium leprae infection.
    Simoes Quaresma JA; de Almeida FA; de Souza Aarao TL; de Miranda Araujo Soares LP; Nunes Magno IM; Fuzii HT; Feio Libonati RM; Xavier MB; Pagliari C; Seixas Duarte MI
    Microbes Infect; 2012 Aug; 14(9):696-701. PubMed ID: 22429842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.
    Hasan Z; Mahmood A; Zafar S; Khan AA; Hussain R
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):35-44. PubMed ID: 15217317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of solute carrier family 11a member 1 and inducible nitric oxide synthase 2 in skin biopsies from leprosy patients.
    Pereira-Suárez AL; Alvarado-Navarro A; Barrietos-García JG; Estrada-Chávez C; Muñoz-Valle JF; Fafutis-Morris M
    Indian J Dermatol Venereol Leprol; 2015; 81(6):594-9. PubMed ID: 26515838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions.
    de Sousa JR; Lucena Neto FD; Sotto MN; Quaresma JAS
    BMC Infect Dis; 2018 Nov; 18(1):576. PubMed ID: 30442123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor (TGF)-beta1, TGF-beta2, and TGF-beta3 and of type I and II TGF-beta receptors during the development of the human fetal ovary.
    Schilling B; Yeh J
    Fertil Steril; 1999 Jul; 72(1):147-53. PubMed ID: 10428164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.